Seres Therapeutics revenue

Seres Therapeutics revenue decreased from $32.1 million in 2017 to $28.3 million in 2018, a 11.9% decrease.

Annual Revenue ($)

Seres Therapeutics revenue was $28.27 m in FY, 2018

Quarterly Revenue ($)

FY, 2016FY, 2017FY, 2018
Revenue$21.77 m$32.10 m$28.27 m
Growth
Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q1, 2019Q2, 2019
Revenue$0$0$2.71 m$3 m$13.02 m$3.02 m$3.01 m$23.02 m$3.97 m$4.61 m$260 k$1.82 m

Annual Growth Rate (%)